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The Finnish Red Cross Blood Service serves as a national 
blood service and a reference laboratory for pre-transfusion 
testing. All challenging antibody identification cases and 
donor phenotyping and genotyping in Finland are thus carried 
out in our laboratory. This optimizes rare donor program 
management in Finland and helps in designing the transfusion 
strategy for patients with a rare blood type.
The Finnish rare donor program has operated for over 
30 years. A blood type is considered rare if its prevalence is 
1 in 1000 or less, with the most common rare phenotypes 
in Finland being LW(a–), Jk(a-b-), and Pk. Because of the 
problematic availability of rare blood, we implemented a 
program for freezing red blood cells (RBCs) in Finland with 
the Haemonetics (Braintree, MA) ACP 215 processing system 
in April 2010. The system is closed, therefore enabling an 
extended shelf life of the units after thawing compared with an 
open system. Based on our validation results, the units are safe 
for use for 7 days after thawing.
At present, we have around 130 donors aged 18–65 years 
with rare blood types in the donor registry, of which about 70 
are active donors with donations in the past 2 years (Table 1). 
During 2012–2014, 12 new rare donors were added to our 
database. Blood types that are globally rare but more common 
in Finland, such as Jk(a–b–) and LW(a–), are represented in 
our donor database and in the stock of frozen RBC units and 
are also available internationally. In 2012–2014, 57 thawed 
and deglycerolized units were distributed domestically 
and 24 deglycerolized and 13 fresh units were distributed 
internationally. With the exception of Vel–, hrS–, and Oh 
(Bombay) blood types, we have been able to meet the need for 
rare blood in Finland using Finnish donors. 
There has been only one international request that could 
not be fulfilled and that was for Rhnull. We have had one 
Rhnull donor (possible regulator type) with no antibodies. 
Unfortunately, that donor is no longer eligible for donation.
A patient with anti-LWa received nine crossmatch-
compatible D– LW(a+) RBC units during a liver transplant-
ation. The transfusion of LW(a+) blood was unavoidable 
because the time of the liver transplantation was not possible 
to foresee, and we could not predict the amount of bleeding 
during the operation. According to the laboratory results, there 
were no signs of hemolysis after the surgery. 
Small incentives are provided to all donors occasionally, but 
there are no extra incentives for rare donors. The rare donors 
are informed about the special importance of their donations 
and about the cryopreservation of RBCs, which makes the 
time point of a donation more flexible and convenient for the 
donor than donations made only on special request.
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Table 1. Rare donors in the Finnish Red Cross Blood Service who 
donated in 2013–2014.
Phenotype Number of donors
Jk(a–b–) 24
LW(a–b+) 19
k– 11
Co(a–) 6
Lu(b–) 5
Pk 4
Vel– 3
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